• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

IVI Research Brief Uses Patient Insights as Foundation for Value

Article

A research brief from the Innovation and Value Initiative (IVI) sought to determine how metastatic non-small lung cancer patients’ perspectives and experiences shape cancer-related treatment decisions.

A research brief from the Innovation and Value Initiative (IVI) sought to determine how metastatic non-small lung cancer (NSCLC) patients’ perspectives and experiences shape cancer-related treatment decisions. IVI constructed in-depth interviews and focus groups with patients with metastatic NSCLC to gain insight into their perspectives on disease burden and treatment.

The research brief identified several broad themes including the need to make frequent trade-offs in treatment decisions and urgency created by the metastatic nature of disease. Patients also identified specific determinants of value in their treatment experience, including personalized care and treatments that offer tolerable side effects.

Read the full research brief.

Related Videos
Jonathan Eisengart
Robin Glasco, Spencer Stuart
Robin Glasco, MBA
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Kara Kelly, MD, chair of pediatrics, Roswell Park Oishei Children's Cancer and Blood Disorders Program
Screenshot of an interview with Nadine Barrett, PhD
Neil Goldfarb, GPBCH
Dr Bonnie Qin
Dr Bonnie Qin
Screenshot of an interview with Ruben Mesa, MD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.